EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Women with suspected diagnosis of ovarian cancer in Ghana: how much do we know about them?

Kwabena Amo-Antwi, Yvonne Nartey, Ramatu Agambire, Lauren Davis-Rivera, Roxanna Haghighat, Bernard Worlasi Ocloo, Adu Appiah-Kubi, Philip Agyemang-Prempeh, George Osei Prempeh, Kofi Dekyi, Ama Yeboah Boakye, Edward Tieru Dassah und 11 weitere

Frontiers in Oncology · 12.03.2026 · 16

DOI: 10.3389/fonc.2026.1771387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 12.03.2026. Verfasst von Kwabena Amo-Antwi und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Addressing disparities in ovarian cancer care between sub-Saharan Africa and other regions begins with the fundamental question, “Who gets ovarian cancer?” This study aimed to identify the demographic and clinical predictors of cancer among women with ovarian tumours.

Methods

We conducted a cross-sectional analysis of women with histology-confirmed ovarian tumour discussed at a multidisciplinary tumour board in a tertiary hospital in Ghana between 2013 and 2024. Descriptive statistics were used to summarise the characteristics of the women, and logistic regression was performed to identify predictors of ovarian cancer. P≤0.05 was considered statistically significant.

Results

Of the 496 women whose data were analysed, 74.4% (n=369) had ovarian cancer. Women diagnosed with ovarian cancer were older than those without cancer (median age 50 years (36-60) vs 39 years (26-55), p<0.001). Most women (274, 55.3%) were married; 297 (59.9%) were multiparous; 291 (58.7%) were urbanites; and more women with cancer were unemployed (93 vs 8, p=0.023). Most women (281, 56.7%) reported abdominal distension. Women with cancer had anaemia (p<0.001), hypertension, diabetes, or other comorbidities (p=0.012). Of the 127 benign tumours, mature cystic teratomas (50, 39.4%), mucinous tumours (28, 22.0%), serous tumours (20, 15.7%), and ovarian fibromas (12, 12.9%) were common. Few (30, 7.5%) and 3 (0.8%) had immunohistochemical and genetic tests, respectively. Travel distance of 100 km or more, (aOR 2.82; 95% CI: 1.21–6.56) postmenopausal status (aOR 6.43; 95% CI: 1.98–20.92), symptom duration of 3–6 months (aOR 2.85; 95% CI: 1.36–5.95), anaemia (aOR 3.74; 95% CI: 1.93–7.25) and hypertension, diabetes, or other comorbidities (aOR 3.74; 95% CI: 1.93–7.25) were predictors of ovarian cancer. Other predictors were tumours with a solid component (aOR 12.97; 95% CI: 3.16–53.18), vascular flow on imaging (aOR 9.53; 95% CI: 4.63–19.65), ascites (aOR 3.62; 95% CI: 1.84–7.14) and elevated serum CA-125 levels (aOR 4.48; 95% CI: 2.32–8.62).

Conclusion

Most women with ovarian tumours were young, and a significant proportion had benign tumours, highlighting the need for a more thorough diagnostic assessment. Improved gynaecological ultrasound scanning, access to intraoperative pathology consultation and molecular testing will be essential for guiding ovarian cancer care in Ghana.

Schlagwörter

Stichwörter der Autor:innen

Ghanaclinical characteristicsdemographic characteristicsepithelial ovarian cancersgerm cell tumoursovarian cancersex cord-stromal tumourssub-Saharan Africa

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Walter Aiden Specialist Clinic, Asokwa-Kumasi, Ghana.
  • Department of Obstetrics and Gynaecology, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
  • Department of Adult Health, School of Nursing and Midwifery, University of Ghana, Accra, Ghana.
  • Department of Nursing and Midwifery, Garden City University College, Kumasi, Ghana.
  • Department of Obstetrics and Gynaecology, Weill Cornell Medical Centre, New York-Presbyterian, New York, NY, United States.

Zitieren

APA

Amo-Antwi, K., Nartey, Y., Agambire, R., Davis-Rivera, L., Haghighat, R., Ocloo, B. W., Appiah-Kubi, A., Agyemang-Prempeh, P., Prempeh, G. O., Dekyi, K., Boakye, A. Y., Dassah, E. T., Tannor, E. K., Ansah, M. B., Akakpo, P. K., Adjei, E., Boateng, N. A., Maxwell, K. N., Adutwum, K. O., …, & Chapman-Davis, E. (2026). Women with suspected diagnosis of ovarian cancer in Ghana: how much do we know about them?. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1771387

Vancouver

Amo-Antwi K, Nartey Y, Agambire R, Davis-Rivera L, Haghighat R, Ocloo BW, et al. Women with suspected diagnosis of ovarian cancer in Ghana: how much do we know about them?. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1771387

BibTeX
@article{AmoAntwi2026,
  author = {Amo-Antwi, Kwabena and Nartey, Yvonne and Agambire, Ramatu and Davis-Rivera, Lauren and Haghighat, Roxanna and Ocloo, Bernard Worlasi and Appiah-Kubi, Adu and Agyemang-Prempeh, Philip and Prempeh, George Osei and Dekyi, Kofi and Boakye, Ama Yeboah and Dassah, Edward Tieru and Tannor, Elliot Koranteng and Ansah, Mavis Bobie and Akakpo, Patrick Kafui and Adjei, Ernest and Boateng, Nana Addo and Maxwell, Kofi Nti and Adutwum, Kwabena Oppong and Ampem-Darkwa, Kwasi and Amo, Bismark Dwobeng and Antwi-Kusi, Akwasi and Chapman-Davis, Eloise},
  title = {Women with suspected diagnosis of ovarian cancer in Ghana: how much do we know about them?},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1771387}
}
Kostenlos starten →